Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Guidance and Visibility -- Ignore unavailable to you. Want to Upgrade?

To: PJr who wrote (175503)	6/27/2008 5:19:24 PM
From: lexi2004	Read Replies (1) \| Respond to of 208838

Hi Pat, HEB...gosh, haven't looked at that one for a long time. Here's a good site for DD that I use. Maybe you can find some info. Looks like the relative strength has improved. moneycentral.msn.com All recent newsEarnings newsHemispherx Biopharma, Inc. Announces Settlement of Arbitration... 6/16/2008PHILADELPHIA, June 16, 2008 (PRIME NEWSWIRE) -- Hemispherx Biopharma, Inc. (AMEX:HEB) today announced that the arbitration proceeding between Hemispherx and Laboratorios del Dr. Esteve ("Esteve") has been settled and is being dismissed by mutual agreement of the parties. PrimeNewswire[video] Wallst.net's '3 Minute Press Show' Features Executive... 6/13/2008NEW YORK, June 13 /PRNewswire-FirstCall/ -- WallSt.net's 3-Minute Press Show is a daily video program hosted by WallSt.net reporter, Tracee Tolentino. Shows air Monday through Friday on:... PRNewswireHemispherx Biopharma, Inc. Completes Enrollment in Phase II... 6/2/2008PHILADELPHIA, June 2, 2008 (PRIME NEWSWIRE) -- Hemispherx Biopharma, Inc. (AMEX:HEB) today reported that it has completed enrollment in a Phase II clinical trial to evaluate the safety and efficacy of Ampligen(r) as an enhancer for seasonal influenza vaccine. PrimeNewswire Lexi